German/Austrian case series describing 11 patients with thrombosis or thrombocytopenia after the AstraZeneca adenoviral-vector vaccine, naming vaccine-induced immune thrombotic thrombocytopenia (VITT); six of the eleven died.
Eleven patients (9 women)… median age 36 years… Nine patients had cerebral venous thrombosis… 6 patients died.
NEJM 2021;384(22):2092-2101
German/Austrian case series describing 11 patients with thrombosis or thrombocytopenia after the AstraZeneca adenoviral-vector vaccine, naming vaccine-induced immune thrombotic thrombocytopenia (VITT); six of the eleven died. The series concerns ChAdOx1 (AstraZeneca), the same VITT/TTS mechanism at issue for the adenoviral J&J vaccine.